Abstract
Nanotechnology-based Targeted Drug Delivery Systems for Lung Cancer is an indispensable resource that will help pharmaceutical scientists and clinical researchers design and develop novel drug delivery systems and devices for the treatment of lung cancer. As recent breakthroughs in nanomedicine are now making it possible to deliver drugs, genes and therapeutic agents to localized areas of disease to maximize clinical benefit, while also limiting unwanted side effects, this book explores promising approaches for the diagnosis and treatment of lung cancer using cutting-edge nanomedical technologies. Topics discussed include polymeric nanoparticles, solid lipid nanoparticles, liposomes, dendrimers, micelles and nanoemulsions.
| Original language | English |
|---|---|
| Title of host publication | Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer |
| Editors | Prashant Kesharwani |
| Publisher | Elsevier |
| Chapter | 9 |
| Pages | 217 |
| Number of pages | 234 |
| Edition | 1 |
| ISBN (Electronic) | 9780128163672 |
| ISBN (Print) | 9780128157206 |
| Publication status | Published (in print/issue) - 31 Jan 2019 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Nanoemulsions as Effective Carriers for the treatment of Lung Cancer'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver